ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol
U.S. Indigenous Communities Start Receiving COVID-19 Vaccines
Federal government's Indian Health Service received about 22,000 vaccine doses Monday
Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i
71 Percent in U.S. Report That They Would Get COVID-19 Vaccine
Twenty-seven percent of Americans remain vaccine-hesitant, with variation across groups, up to 42 percent among Republicans
High-Income Countries Have Secured COVID-19 Vaccine Supplies
Up to 40 percent of vaccine courses from manufacturers might remain for low- and middle-income countries by end of 2021
Effect of Siponimod on Cognition in MS Patients Explored
Mixed results seen for effect of siponimod on cognitive processing speed in patients with secondary progressive multiple sclerosis
Alaska HCW First in U.S. to Have Allergic Reaction to COVID-19 Vaccine
Worker felt flushed within 10 minutes of receiving vaccine, followed by shortness of breath and elevated heart rate
Outpatient Buprenorphine Dispensing Up During COVID-19
Findings limited to Texas, in the early days following changes in federal regulation due to the pandemic
Socioeconomic Status Tied to Inflammatory Bowel Disease Outcomes
Association greater for Crohn disease versus ulcerative colitis
